Biogen Inc (NASDAQ: BIIB)
DRUGS - Biotechnology
Stock price data as of 01/18/2019
Closing price: 337.42
- BIIB is one of this week's most volatile stocks in the S&P-100 with an estimated annualized standard deviation of 33.9%.
- Volatility is forecast to fall over the next month.
- BIIB is above its 200-day moving average, providing a measure of support for long positions.
- With RSI > 70, BIIB is overbought. Odds slightly favor a short-term price reversal.
- Price broke above prior resistance level - a short-term bullish signal.
||Price as % of Range
(Annualized standard deviation)
||Next month forecast
There is an estimated 5% probability that the stock price of Biogen Inc will fall by more than:
- 9.2% in the next week.
- 19.8% in the next month.
- 59.4% in the next year.